Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationHematopoiesisRecurrenceCombined Modality TherapyRadiation ChimeraMice, Inbred C57BLTreatment OutcomeLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationLeukemia, Myeloid, AcuteTime FactorsImmunosuppressive AgentsRemission InductionGraft RejectionHematologic NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingBone Marrow NeoplasmsTransplantation ImmunologyGraft vs Host ReactionLeukemia, MyeloidImmunosuppressionLymphocyte DepletionStem Cell TransplantationAcute DiseaseRetrospective StudiesLymphoma, Non-HodgkinLeukocyte TransfusionHeart TransplantationSevere Combined ImmunodeficiencySurvival AnalysisChimeraT-LymphocytesColony-Forming Units AssayHLA AntigensMyelodysplastic SyndromesLung TransplantationActuarial AnalysisHematologic DiseasesBone DensityCyclosporineLymphocyte TransfusionFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilyOrgan TransplantationCarmustinePancytopeniaSurvival RateCell DifferentiationGraft vs Tumor EffectGraft vs Leukemia EffectLeukocyte CountCytarabineCytomegalovirus InfectionsSpleenBone ResorptionGranulocyte Colony-Stimulating FactorMelphalanDisease-Free SurvivalMice, Inbred BALB CEtoposideLymphomaFlow CytometryMultiple MyelomaCells, CulturedFatal OutcomePrognosisHodgkin DiseaseAntigens, CD34InfectionMice, KnockoutCell TransplantationCord Blood Stem Cell TransplantationGranulocytes